AFNI Message Board

Dear AFNI users-

We are very pleased to announce that the new AFNI Message Board framework is up! Please join us at:

https://discuss.afni.nimh.nih.gov

Existing user accounts have been migrated, so returning users can login by requesting a password reset. New users can create accounts, as well, through a standard account creation process. Please note that these setup emails might initially go to spam folders (esp. for NIH users!), so please check those locations in the beginning.

The current Message Board discussion threads have been migrated to the new framework. The current Message Board will remain visible, but read-only, for a little while.

Sincerely, AFNI HQ

History of AFNI updates  

|
January 20, 2003 12:52PM

Hello Rutger:

Yes, Sally and Andy are correct. By entering Subject as a Random Factor,
the ANOVA DOES take into account the fact that the same measurements were
repeated in a single subject. For example, a two-factor ANOVA, with 2 levels
for the fixed factor A, and Subject as the Random Factor B, is equivalent to
a paired t-test.

The second study that you described sounds like a 3 factor crossed-nested
ANOVA, with random factor C (Subject) nested with fixed factor A (Group).
See the documentation in file 3dANOVA.ps for program 3dANOVA3.

However, let me suggest an alternative approach to the analysis. The major
difficulty with comparing fMRI measurement results across subjects is that
people's brains are different. Now, in order to compensate for the variation
in neural anatomy, we "normalize" the brains by TLRC transformation followed
by Gaussian blurring. However, this is, at best, an imperfect solution.

Because of the difficulties inherent in the across-subject analysis, I prefer
to delay the across-subject comparisons as late as possible in the data
analysis stream. That is, I think it is better to perform as much of the
analysis within-subject (using the ORIG data) as possible.

I don't know the details of your experiments. However, I believe that it is
possible to extract the Drug vs. Baseline, and Placebo vs. Baseline, response
for each individual subject before it is necessary to compare results across
subjects. That is, you can carefully concatenate runs (within-subject only!),
and then use the "-glt" option of program 3dDeconvolve to calculate the
relative differences in response for each subject. Then, only this final
result need be TLRC'd and blurred, before using, say, a t-test to compare
the groups. See the documentation in file 3dDeconvolve.ps for more details.

The same reasoning applies to your first question about comparing medication
regimes for different subjects. First, compare the medication regimes within
the individual subjects, then combine results across subjects.

Opinions expressed herein are only those of the author.

Doug Ward
Subject Author Posted

Repeated Measures Design

Rutger Goekoop January 10, 2003 10:38AM

Re: Repeated Measures Design

Andrew Mayer January 16, 2003 10:45PM

Re: Repeated Measures Design

Rutger Goekoop January 17, 2003 03:39AM

Re: Repeated Measures Design (Right, Doug?)

sally durgerian January 17, 2003 11:06AM

Re: Repeated Measures Design (Right, Doug?)

Rutger Goekoop January 20, 2003 10:25AM

Re: Repeated Measures Design (Right, Doug?)

B. Douglas Ward January 20, 2003 12:52PM

Re: Repeated Measures Design (Right, Doug?)

sally durgerian January 20, 2003 04:34PM

Re: Thanks

Rutger Goekoop January 21, 2003 04:35AM